Chemotherapy with the EDP-mitotane regimen appears to have better outcomes in patients with adrenocortical cancer as compared to the streptozocin-mitotane regimen.
Friday, 15 June 2012
Can Combination Chemotherapy Improve Prognosis of Adrenocortical Cancer? | MedIndia
Can Combination Chemotherapy Improve Prognosis of Adrenocortical Cancer? | MedIndia
Chemotherapy with the EDP-mitotane regimen appears to have better outcomes in patients with adrenocortical cancer as compared to the streptozocin-mitotane regimen.
http://www.medindia.net/news/healthinfocus/can-combination-chemotherapy-improve-prognosis-of-adrenocortical-cancer-102716-1.htm
Chemotherapy with the EDP-mitotane regimen appears to have better outcomes in patients with adrenocortical cancer as compared to the streptozocin-mitotane regimen.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment